Where does Eyebright Medical Technology (BEIJING) Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Eyebright Medical Technology (BEIJING) Co., Ltd. ranks #31,593 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Eyebright Medical Technology (BEIJING) Co., Ltd. hold?

Eyebright Medical Technology (BEIJING) Co., Ltd. holds 8 US utility patents granted between 2018 and 2025, spanning 10 technology areas.

What is Eyebright Medical Technology (BEIJING) Co., Ltd.'s Innovation Score?

Eyebright Medical Technology (BEIJING) Co., Ltd. has an Innovation Score of 48.7 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Eyebright Medical Technology (BEIJING) Co., Ltd.'s patent grant rate increasing or decreasing?

Eyebright Medical Technology (BEIJING) Co., Ltd.'s recent grant velocity is +500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Eyebright Medical Technology (BEIJING) Co., Ltd.'s patents?

Eyebright Medical Technology (BEIJING) Co., Ltd.'s patents average 16.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Eyebright Medical Technology (BEIJING) Co., Ltd.

Q: What technology areas does Eyebright Medical Technology (BEIJING) Co., Ltd. focus on?

Eyebright Medical Technology (BEIJING) Co., Ltd.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 8 patents, ranking #786 of 3,082 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Q: How is the Eyebright Medical Technology (BEIJING) Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 8 granted patents across 10 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Eyebright ranks #31,593 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 10 technology areas.

#31,593
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.7/100): 16.5
avg claims per patent: +500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31593 · Foreign Corporation #31,593 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,593/49,997
PHOTO-FINISH East Jordan Plastics
CPC-FOCUS A61F · 10 areas
INNOV-PAR 48.7/100
CLAIMS-RICH 16.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: East Jordan Plastics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Eyebright’s 48.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (16%) Velocity 20.0 pts (41%) Breadth 11.2 pts (23%) Claim depth 9.9 pts (20%)

Qualcomm Incorporated · highest

85
Eyebright Medical… · this assignee

49
3D Lighting… · lowest

7

What this shows Eyebright's Innovation Score is 48.7/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Eyebright?

Each dot is one of Eyebright’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Eyebright’s own 16.5 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Eyebright vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Eyebright's grants concentrate

Eyebright Medical Technology (BEIJING) Co., Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2018. By volume, Eyebright sits between Evonetix Ltd and Eastman Outdoors, LLC.

Eyebright's three-year grant acceleration

Eyebright Medical Technology (BEIJING) Co., Ltd. shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Evonetix

8
EX

8
Exel Industries

8
Exide

8
Ezero

8
Ezmems

8
East Jordan Plast…

8
Eastman Outdoors

8
Eyebright Medical… ◀

8

What this shows Eyebright holds 8 patents at rank #31,538, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Eyebright

By rank, the assignees closest to #31,538 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Eyebright's primary technology class.

Eyebright's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Eyebright Medical Technology (BEIJING) Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	12.5%
2020	1	12.5%
2022	2	25.0%
2023	2	25.0%
2024	1	12.5%
2025partial year	1	12.5%

Which technologies does Eyebright Medical Technology (BEIJING) Co., Ltd. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 5

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 5

A61B - DIAGNOSIS; SURGERY; Identification 3

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

G02B - Optical Elements, Systems OR Apparatus 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Eyebright Medical Technology (BEIJING) Co., Ltd.'s patent record in context - here's where to go next.

Eyebright Medical Technology (BEIJING) Co., Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #31,593 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Eyebright Medical Technology (BEIJING) Co., Ltd. against Evonetix Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.